Hypoxia-induced Bcl-2 expression in endothelial cells via p38 MAPK pathway

Biochemical and Biophysical Research Communications

Volumn 394, Issue 4, 2010, Pages 976-980

  Zhang, Cui Li ^a   Song, Fei ^b   Zhang, Jing ^a   Song, Q H ^c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARVARD UNIVERSITY   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Angiogenesis; Bcl 2; Endothelial cells; Hypoxia; siRNA

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; HYPOXIA INDUCIBLE FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REOXYGENATION; WESTERN BLOTTING;

ANIMALS; ANOXIA; CELL LINE; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 77950938618     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.102     Document Type: Article

References (25)

1. Mallick S., Patil R., Gyanchandani R., Pawar S., Palve V., Kannan S., Pathak K.A., Choudhary M., and Teni T.R. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1. J. Pathol. 217 (2009) 398-407
2. Ferrer M.D., Tauler P., Sureda A., Tur J.A., and Pons A. Antioxidant regulatory mechanisms in neutrophils and lymphocytes after intense exercise. J. Sports Sci. 27 (2009) 49-58
3. Yang M., Cao X., Yu M.C., Gu J.F., Shen Z.H., Ding M., Yu B., Zheng S., and Liu X. Potent antitumor efficacy of ST13 for colorectal cancer mediated by oncolytic adenovirus via mitochondrial apoptotic cell death. Hum. Gene Ther. 19 (2008) 343-353
4. Wu J.N., Huang J., Yang J., Tashiro S., Onodera S., and Ikejima T. Caspase inhibition augmented oridonin-induced cell death in murine fibrosarcoma l929 by enhancing reactive oxygen species generation. J. Pharmacol. Sci. 108 (2008) 32-39
5. Yang K.C., Wu C.C., Wu C.H., Chen J.H., Chu C.H., Chen C.H., Chou Y.H., Wang Y.J., Lee W.S., Tseng H., Lin S.Y., Lee C.H., and Ho Y.S. Involvement of proapoptotic Bcl-2 family members in terbinafine-induced mitochondrial dysfunction and apoptosis in HL60 cells. Food Chem. Toxicol. 44 (2006) 214-226
6. Moungjaroen J., Nimmannit U., Callery P.S., Wang L., Azad N., Lipipun V., Chanvorachote P., and Rojanasakul Y. Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation. J. Pharmacol. Exp. Ther. 319 (2006) 1062-1069
7. Daly C., Wong V., Burova E., Wei Y., Zabski S., Griffiths J., Lai K.M., Lin H.C., Ioffe E., Yancopoulos G.D., and Rudge J.S. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. 18 (2004) 1060-1071
8. Xu J., Lü X.W., Huang Y., Zhu P.L., and Synergism J.Li. Synergism of simvastatin with losartan prevents angiotensin II-induced cardiomyocyte apoptosis in vitro. J. Pharm. Pharmacol. 61 (2009) 503-510
9. Jamnicki-Abegg M., Weihrauch D., Pagel P.S., Kersten J.R., Bosnjak Z.J., Warltier D.C., and Bienengraeber M.W. Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology 103 (2005) 1006-1014
10. Jay S.M., Shepherd B.R., Bertram J.P., Pober J.S., and Saltzman W.M. Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J. 22 (2008) 2949-2956
11. Arakawa M., Yasutake M., Miyamoto M., Takano T., Asoh S., and Ohta S. Transduction of anti-cell death protein FNK protects isolated rat hearts from myocardial infarction induced by ischemia/reperfusion. Life Sci. 80 (2007) 2076-2084
12. Burke C., Sinclair K., Cowin G., Rose S., Pat B., Gobe G., and Colditz P. Intrauterine growth restriction due to uteroplacental vascular insufficiency leads to increased hypoxia-induced cerebral apoptosis in newborn piglets. Brain Res. 1098 (2006) 19-25
13. Kienle K., Rentsch M., Müller T., Engelhard N., Vogel M., Jauch K.W., and Beham A. Expression of BCL-2 in liver grafts after adenoviral transfer improves survival following prolonged ischemia and reperfusion in rat liver transplantation. Transplant Proc. 37 (2005) 439-441
14. Gobé G., Zhang X.J., Cuttle L., Pat B., Willgoss D., Hancock J., Barnard R., and Endre R.B. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure. Immunol. Cell Biol. 77 (1999) 279-286
15. Guthridge M.A., Barry E.F., Felquer F.A., McClure B.J., Stomski F.C., Ramshaw H., and Lopez A.F. The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-kappaB and induction of Bcl-2. Blood 103 (2004) 820-827
16. Liu H., and Pope R.M. The role of apoptosis in rheumatoid arthritis. Curr. Opin. Pharmacol. 3 (2003) 317-322
17. DiPaola R.S., Patel J., and Rafi M.M. Targeting apoptosis in prostate cancer. Hematol. Oncol. Clin. North Am. 15 (2001) 509-524
18. Conner E.A., Teramoto T., Wirth P.J., Kiss A., Garfield S., and Thorgeirsson S.S. HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1. Carcinogenesis 20 (1999) 583-590
19. Ho S., Winkler-Lowen B., Morrish D.W., Dakour J., Li H., and Guilbert L.J. The role of Bcl-2 expression in EGF inhibition of TNF-alpha/IFN-gamma-induced villous trophoblast apoptosis. Placenta 20 (1999) 423-430
20. Gerber H.P., Dixit V., and Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273 (1998) 13313-13316
21. Baek J.H., Jang J.E., Kang C.M., Chung H.Y., Kim N.D., and Kim K.W. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 19 (2000) 4621-4631
22. Vera Y., Erkkilä K., Wang C., Nunez C., Kyttänen S., Lue Y., Dunkel L., Swerdloff R.S., and Sinha Hikim A.P. Involvement of p38 mitogen-activated protein kinase and inducible nitric oxide synthase in apoptotic signaling of murine and human male germ cells after hormone deprivation. Mol. Endocrinol. 20 (2006) 1597-1609
23. Choi K.S., Park J.T., and Dumler J.S. Anaplasma phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-activated protein kinase signal pathway. Infect. Immun. 73 (2005) 8209-8218
24. Biroccio A., Candiloro A., Mottolese M., Sapora O., Albini A., Zupi G., and Del Bufalo D. Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. FASEB J. 14 (2000) 652-660
25. Trisciuoglio D., Iervolino A., Zupi G., and Del Bufalo D. Involvement of PI3K and MAPK signaling in Bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol. Biol. Cell 16 (2005) 4153-4162